Preliminary analysis of huntington’s disease in South Korea

Journal of Huntington's Disease

Volumn 2, Issue 1, 2013, Pages 83-87

  Shin, Chae Won ^a   Choi, Yoon Jae ^a   Kim, Manho ^a   Jeon, Beom Seok ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Chorea; Demographics; Genetics; Huntington disease; Trinucleotide repeat expansion

Indexed keywords

ADULT; AGED; ARTICLE; CHOREA; DEMOGRAPHICS; FEMALE; GENETICS; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; ONSET AGE; SOUTH KOREA; TRINUCLEOTIDE REPEAT; YOUNG ADULT;

CHOREA; DEMOGRAPHICS; GENETICS; HUNTINGTON DISEASE; TRINUCLEOTIDE REPEAT EXPANSION;

ADULT; AGE OF ONSET; AGED; CHOREA; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; REPUBLIC OF KOREA; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84897918370     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-120040     Document Type: Article

References (21)

1. Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Mov Disord. 2012;27(9): 1083-91.
2. Chang CM, Yu YL, Fong KY, Wong MT, Chan YW, Ng TH, et al. Huntington’s disease in Hong Kong Chinese: Epidemiology and clinical picture. Clinical and Experimental Neurology. 1994;31: 43-51.
3. Nakashima K, Watanabe Y, Kusumi M, Nanba E, Maeoka Y, Nakagawa M, et al. Epidemiological and genetic studies of Huntington’s disease in the San-in area of Japan. Neuroepidemiology. 1996;15: 126-31.
4. Chen YY, Lai CH. Nationwide population-based epidemiologic study of Huntington’s Disease in Taiwan. Neuroepidemiology. 2010;35: 250-4.
5. Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL, et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. European Journal of Human Genetics: EJHG. 2011;19: 561-6.
6. Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, et al.Aworldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994;330: 1401-6.
7. Shoulson I, Young AB. Milestones in huntington disease.Mov Disord. 2011;26: 1127-33.
8. Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78: 690-5.
9. Ross CA, Tabrizi SJ. Huntington’s disease: From molecular pathogenesis to clinical treatment. Lancet Neurology. 2011;10: 83-98.
10. Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M. Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg. 1997;99(Suppl 2): S6-10.
11. Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, et al. Rate of functional decline in Huntington’s disease. Huntington Study Group. Neurology. 2000;54: 452-8.
12. Unified Huntington’s Disease Rating Scale (UHDRS): Reliability and consistency. Huntington Study Group. Mov Disord. 1996;11: 136-42.
13. Leung CM, Chan YW, Chang CM, Yu YL, Chen CN. Huntington’s disease in Chinese: Ahypothesis of its origin. Journal of Neurology, Neurosurgery, and Psychiatry. 1992;55: 681-4.
14. James CM, Houlihan GD, Snell RG, Cheadle JP, Harper PS. Late-onset. Huntington’s disease: A clinical and molecular study. Age and Ageing. 1994;23: 445-8.
15. Lipe H, Bird T. Late onset Huntington Disease: Clinical and genetic characteristics of 34 cases. Journal of the Neurological Sciences. 2009;276: 159-62.
16. Gonzalez-Alegre P, Afifi AK. Clinical characteristics of childhood-onset (juvenile) Huntington disease: Report of 12 patients and review of the literature. J Child Neurol. 2006;21: 223-9.
17. Ruocco HH, Lopes-Cendes I, Laurito TL, Li LM, Cendes F. Clinical presentation of juvenile Huntington disease. Arquivos de neuro-psiquiatria. 2006;64: 5-9.
18. AlmqvistEW, Elterman DS, MacLeod PM, HaydenMR.High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clinical Genetics. 2001;60: 198-205.
19. Ramos-Arroyo MA, Moreno S, Valiente A. Incidence and mutation rates of Huntington’s disease in Spain: Experience 9 years of direct genetic testing. Journal of Neurology, Neurosurgery, and Psychiatry. 2005;76: 337-42.
20. Panas M, Karadima G, Vassos E, Kalfakis N, Kladi A, Christodoulou K, et al. Huntington’s disease in Greece: The experience of 14 years. Clinical Genetics. 2011;80: 586-90.
21. Kartsaki E, Spanaki C, Tzagournissakis M, Petsakou A, Moschonas N, Macdonald M, et al. Late-onset and typical Huntington disease families from Crete have distinct genetic origins. International Journal of Molecular Medicine. 2006;17: 335-46.